Research on the Efficacy and Safety of Targeted Suprachiasmatic Nucleus Electrical Stimulation for Improving Metabolic Disorders in Patients With Stable Bipolar Disorder Comorbid With Obesity
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Temporal Interference Stimulation, Sham Temporal Interference Stimulation Arm Description.
- Who it may be relevant to
- Registry conditions: Bipolar Disorder (BD). Basic parameters: 18 years — 45 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- China
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Research on the Efficacy and Safety of Targeted Suprachiasmatic Nucleus Electrical Stimulation for Improving Metabolic Disorders in Patients With Stable Bipolar Disordercomorbid With Obesity
Overview
This study aims to stabilize the patients with bipolar disorder (BD) comorbid with obesity in the stable phase by using temporal interference stimulation (TIS ) intervention. It intends to investigate the changes in key metabolic molecules such as GLP-1 circadian rhythm, and further explore the molecular mechanism of their metabolic disorders.
Interventions
- Other Temporal Interference Stimulation
TIS treatment lasts for 20 minutes, with the maximum output current being 2mA, which is adjusted according to the individual head model. The two pairs of electrical stimulation frequencies in tTIS are 1000Hz and 1040Hz. - Other Sham Temporal Interference Stimulation Arm Description
The stimulus intensity was 20% of MT in the Sham Comparator arm, and the remaining parameters werethe same as the Active Comparator arm.
Primary outcome measures
- GLP level [Time frame: 0-2week]
Eligibility criteria
Inclusion criteria
- Both biological parents are of Han ethnicity;
- Age range: 18 to 45 years old, gender not restricted;
- Meets the clinical diagnostic criteria for bipolar disorder as stipulated in the 5th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5);
- Body Mass Index (BMI) ≥ 28 kg/m2, or for males, waist circumference ≥ 90 cm and for females, waist circumference ≥ 85 cm;
- HAMD-24 score < 7 points, YMRS score < 5 points;
- All included researchers and their family members have given informed consent for this study.
Exclusion criteria
221/5000
- Individuals with other DSM-5 spectrum disorders;
- Mental disorders caused by substance abuse (such as alcohol, drugs, etc.), and those with severe physical illnesses;
- Those who consumed food or microecological preparations containing probiotics, prebiotics, etc. within one week before enrollment, and had a history of respiratory, urinary, digestive system infections and antibiotic use within one month before enrollment;
- Those currently having serious suicidal thoughts or behaviors, or those with severe agitation;
- Those who cannot follow medical advice for treatment, or those without guardians;
- Pregnant or lactating women, or those planning to become pregnant;
- Those who cannot complete MRI examinations due to special conditions such as having metal implants or pacemakers in their bodies.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Single blind
- Primary purpose
- Treatment
Study locations
China · 1 center
- First Affiliated Hospital of Zhejiang University — Hangzhou
Publications
- 0
Identifiers
NCT: NCT07589647 · IIT20260026C-R1